Share:
Home
About Us
History
Mission
Subsidiaries
Alliances
Management Team
Career Opportunities
Technology & Science
Protectan Technology
Curaxin Technology
Publications
Product Pipeline
CBLB502 Oncology
CBLB502 Biodefense
CBLB612
CBL0102
CBL0137
Revercom
Mobilan
Arkil
Antimycon
Xenomycins
Business Development
Licensing Opportunities
Investors
Overview
News / Events
Stock Information
Financial Information
SEC Filings
Corporate Governance
Overview
News / Events
Press Releases
Events & Presentations
Email Alerts
Company Information
Management Team
FAQ
Contact Us
Stock Information
Stock Quote & Chart
Historical Quotes
Analyst Coverage
Institutional Ownership
Financial Information
Financials
Annual Reports and Proxy Materials
SEC Filings
All SEC Filings
Insider Ownership
Corporate Governance
Board of Directors
Board Committees
Governance Documents
Shareholder Tools
Shareholder Briefcase
Printed Materials
Email Alerts
Download Library
Snapshot
RSS News Feeds
Search Investor Relations
Financial Information
Email Alerts
Tear Sheet
Contact Us
RSS News Feed
Here you will find a summary of Cleveland BioLabs, Inc.'s latest financial information.
Latest 10-Q
Date Filed
Format
Size
Form 10-Q
May 9, 2013
430.3 KB
Latest Annual Report and 10-K
Date Filed
Format
Size
2012 Annual Report
2.3 MB
Form 10-K/A
Apr 30, 2013
312.2 KB
Form 10-K
Mar 18, 2013
958.4 KB
Latest Proxy Statement
Date Filed
Format
Size
Proxy Statement
May 17, 2013
697.6 KB
Proxy Statement (PRE 14A)
May 7, 2013
697.3 KB
= add PDF file to Briefcase
You are now leaving this website. If you would like to continue, click Continue.
Cancel
Continue